Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis

Tai‐Li Chen, Jing‐Yang Huang, Hui-Yun Lin, Yun-Ting Chang, Cheng‐Yuan Li, James Cheng-Chung Wei

2024Journal of the American Academy of Dermatology11 citationsDOI

Topics & Concepts

MedicinePsoriatic arthritisPsoriasisInterleukinTumor necrosis factor alphaArthritisTumor necrosis factor αInterleukin 6Internal medicineImmunologyDermatologyCytokinePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and Therapies